Civitas Therapeutics Appoints Bryan E. Stuart Chief Business Officer  
9/5/2012 9:53:09 AM

CHELSEA, Mass.--(BUSINESS WIRE)--Civitas Therapeutics, a privately-held pharmaceutical company developing inhaled therapeutics with the clinically-proven ARCUS(TM) dry powder platform, today announced that Bryan Stuart has been appointed Chief Business Officer. In this role Mr. Stuart will lead the company’s corporate development and business development efforts, and he will serve as a member of the company’s executive leadership team.